FDA demonizes vape industry by banning Juul products

New York, June 23, 2022 (GLOBE NEWSWIRE) — According to the Wall Street Journal, the Food and Drug Administration could order Juul to withdraw its vape from the U.S. market as early as this week. The Blink Group Inc., the regulation-focused designer and provider of premium, custom, and bespoke vaporizer technology, finds the FDA’s potential decision only fuels the government’s “war” on tobacco, which is not based on any scientific evidence.

“If the FDA took the time to look at the science surrounding vaping, rather than knee-jerkly reacting to statistics about teenage use, they would see that vaping is the key for countless individuals trying to quit smoking advantage was. For years, European markets have embraced vape as such a necessary smoking cessation tool that they have been offering health insurance breaks to those who vape.

If you look down at what this decision could mean for the cannabis vape industry, the federal illegality of cannabis will keep the space safe for now as the FDA is unwilling to regulate the industry while it is a Schedule 1 drug remains. However, this does not mean that this will be the case forever. I hope by this point the FDA will recognize that vaping is considered one of the safest methods of consumption, especially for medical patients looking for the purest stream of cannabinoids and terpenes, and the lack of a burn means less dangerous substances and it’s easier on the lungs.

The EVALI crisis that hit the e-cigarette and e-cigarette markets a few years ago was proven to be the result of illegal products. If the FDA really wants to keep consumers safe, they should regulate vaporizer companies and hold them to the highest scientific standards, rather than banning products that they send straight back to the black market and only make the problem worse,” said Arnaud Dumas de Rauly . CEO and co-founder of the Blinc Group.

Dumas de Rauly is currently Chair of the ISO…